Montgomery Village, MD, United States of America

Argaw Kidane

This inventor holds 24 USPTO granted patents and 18 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Supernus Pharmaceuticals, Inc., United Therapeutics Corporation. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Argaw Kidane. Retrieved from https://idiyas.com/inventor/argaw-kidane

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 18)

% Patents Active = 83.3

CIPO Patents = 1

EPO Patents = 8 (Patent Applications = 5)

Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 177(Granted Patents)

Company Filing History:

23 out of 83

Supernus Pharmaceuticals, Inc.

patents

1 out of 133

United Therapeutics Corporation

patents

Years Active: 2008-2024

Loading Chart...

Areas of Expertise:

Osmotic Drug Delivery

Modified Release Preparations

Oxcarbazepine

Trospium

Bioavailability Enhancers

Quaternary Ammonium Compounds

Therapeutic Compounds

Once Daily Dosage Forms

Seizure Treatment

Bladder Dysfunction

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11896599 - Modified release preparations containing oxcarbazepine and derivatives thereof (2024-02-13),

2. 11166960 - Modified release preparations containing oxcarbazepine and derivatives thereof (2021-11-09),

3. 10220042 - Modified release preparations containing oxcarbazepine and derivatives thereof (2019-03-05),

4. 10154965 - Osmotic drug delivery system (2018-12-18),

5. 9855278 - Modified release preparations containing oxcarbazepine and derivatives thereof (2018-01-02),

6. 9393203 - Osmotic drug delivery system (2016-07-19),

7. 9370525 - Modified release preparations containing oxcarbazepine and derivatives thereof (2016-06-21),

8. 9351975 - Modified release preparations containing oxcarbazepine and derivatives thereof (2016-05-31),

9. 9119792 - Modified release preparations containing oxcarbazepine and derivatives thereof (2015-09-01),

10. 9119791 - Modified release preparations containing oxcarbazepine and derivatives thereof (2015-09-01),

11. 8821930 - Modified release preparations containing oxcarbazepine and derivatives thereof (2014-09-02),

12. 8747897 - Osmotic drug delivery system (2014-06-10),

13. 8709476 - Compositions of quaternary ammonium compounds containing bioavailability enhancers (2014-04-29),

14. 8617600 - Modified release preparations containing oxcarbazepine and derivatives thereof (2013-12-31),

15. 8211464 - Modified release preparations containing oxcarbazepine and derivatives thereof (2012-07-03),

Title: **The Innovative Contributions of Argaw Kidane in Pharmaceutical Patents**

Introduction

Argaw Kidane, based in Montgomery Village, MD, is a prominent inventor with a remarkable portfolio of 24 patents. His work primarily focuses on innovative pharmaceutical preparations, contributing significantly to advancements in drug release technologies.

Latest Patents

Among his most notable patents are the modified release preparations containing oxcarbazepine and its derivatives. These patents detail controlled-release formulations designed for once-a-day administration. The inventive compositions incorporate solubility- and/or release-enhancing agents that offer tailored drug release profiles, specifically aiming for sigmoidal release profiles. Additionally, methods of treatment utilizing these inventive compositions are also disclosed, underscoring the therapeutic potential of his innovations.

Career Highlights

Argaw Kidane has established a robust career in the pharmaceutical industry, with significant contributions made while working at Supernus Pharmaceuticals, Inc. His expertise in developing controlled-release formulations has set a new standard in medication management, providing patients with more effective treatment options.

Collaborations

Throughout his career, Kidane has collaborated with notable professionals in the field, including colleagues Padmanabh P. Bhatt and Kevin Edwards. These partnerships have played an integral role in advancing the innovative projects he has led.

Conclusion

Argaw Kidane's extensive patent portfolio reflects his dedication to pharmaceutical innovation. His contributions not only enhance medication efficacy but also improve patient compliance through better drug delivery systems. With ongoing advancements in his research, Kidane continues to be a significant figure in the pharmaceutical landscape.

Profile summary based on public USPTO records.